JPH0272888A - Production of l-valine - Google Patents
Production of l-valineInfo
- Publication number
- JPH0272888A JPH0272888A JP22141188A JP22141188A JPH0272888A JP H0272888 A JPH0272888 A JP H0272888A JP 22141188 A JP22141188 A JP 22141188A JP 22141188 A JP22141188 A JP 22141188A JP H0272888 A JPH0272888 A JP H0272888A
- Authority
- JP
- Japan
- Prior art keywords
- valine
- reaction
- glucose
- biotin
- nitrogen source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 title claims abstract description 38
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 42
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 23
- 239000008103 glucose Substances 0.000 claims abstract description 23
- 229960004295 valine Drugs 0.000 claims abstract description 23
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 13
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 13
- 239000007864 aqueous solution Substances 0.000 claims abstract description 12
- 230000000813 microbial effect Effects 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 241000186031 Corynebacteriaceae Species 0.000 claims description 6
- 244000005700 microbiome Species 0.000 abstract description 12
- 241000319304 [Brevibacterium] flavum Species 0.000 abstract description 9
- 241000186254 coryneform bacterium Species 0.000 abstract 2
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 16
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 8
- 239000004474 valine Substances 0.000 description 8
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 235000020958 biotin Nutrition 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 241000186146 Brevibacterium Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、酵素反応によるし一バリンの製造法に関する
ものである。DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to a method for producing valine by enzymatic reaction.
本発明によれば、高収量で効率よくし一ノ<リンを製造
することができる。According to the present invention, it is possible to efficiently produce ichinorin with high yield.
L−バリンは、必須アミノ酸の一つとして人間及び動物
の栄養上重要な役割をするもので、医薬、食品、飼料添
加剤等の需要が近年急激に増加している。L-valine plays an important role in the nutrition of humans and animals as one of the essential amino acids, and demand for pharmaceuticals, foods, feed additives, etc. has increased rapidly in recent years.
(従来の技術と課題)
L−バリンの工業的製造法としては、他のアミノ酸の場
合と同様に立体異性体が存在するので、化学的合成法で
はL一体のみの製造は困難となり、主として醗酵法によ
っている。(Prior art and issues) As for the industrial production method of L-valine, since stereoisomers exist as in the case of other amino acids, it is difficult to produce only L-valine using chemical synthesis methods, and the main method is fermentation. It's according to the law.
しかしながら、公知の醗酵法によるし一バリンの製造で
は、L−バリンの蓄積に限界があり、新たな観点でL−
バリンを著量生成させる方法の提供が求められている。However, in the production of L-valine using the known fermentation method, there is a limit to the accumulation of L-valine.
There is a need to provide a method for producing significant amounts of valine.
本発明者らは先に、グルコースを含有する水溶液中で、
ビオチン要求性のコリネ型細菌に属する微生物を酵素源
として用いて酵素反応させ、該水溶液中にL−バリンを
収率良く製造する方法(特願昭62−101677号)
を提案している。The present inventors previously demonstrated that in an aqueous solution containing glucose,
A method for producing L-valine in a high yield in an aqueous solution by carrying out an enzymatic reaction using microorganisms belonging to coryneform bacteria that require biotin as an enzyme source (Japanese Patent Application No. 101677/1982)
is proposed.
(発明の構成及び効果)
本発明者らは、さらに効率良くL−バリンを製造させる
目的で、反応液組成等について鋭意検討した結果、ビオ
チン要求性のコリネ型!Il菌に屈する微生物菌体を、
グルコースと窒素源を含有する水溶液にて酵素反応させ
て該溶液中にI、−バリンを生成せしめるに際し、該溶
液中のグルコース重量と窒素源の窒素重量の比(以下C
/N比という)を5〜40の範囲で酵素反応を行うこと
により高収率でL−バリンを製造出来ることを見出し、
本発明に到達した。(Structure and Effects of the Invention) In order to produce L-valine more efficiently, the present inventors have conducted extensive studies on the composition of the reaction solution, etc. As a result, the present inventors have found that a biotin-requiring Corine type product has been obtained. Microbial cells that succumb to Il bacteria,
When performing an enzymatic reaction in an aqueous solution containing glucose and a nitrogen source to produce I,-valine in the solution, the ratio of the weight of glucose in the solution to the weight of nitrogen in the nitrogen source (hereinafter referred to as C
We discovered that L-valine can be produced in high yield by carrying out an enzymatic reaction at a ratio of 5 to 40.
We have arrived at the present invention.
本発明によれば、グルコースと窒素源を含有する水溶液
中で、ビオチン要求性のコリネ型細菌に属する微生物を
酵素源として用いて、酵素反応させるに際し、該水溶液
中のC/N比を5〜40の範囲で反応を実施することに
より、グルコースの消費量を大幅に低減化出来、その結
果L−バリンの対グルコース収率を大幅に向上させるこ
とが可能となった。従って本発明の方法によれば、Lバ
リンを工業的に効率よく製造できる。According to the present invention, when performing an enzyme reaction in an aqueous solution containing glucose and a nitrogen source using a biotin-requiring microorganism belonging to coryneform bacteria as an enzyme source, the C/N ratio in the aqueous solution is set to 5 to 5. By carrying out the reaction in the range of 40, it was possible to significantly reduce the amount of glucose consumed, and as a result, it became possible to significantly improve the yield of L-valine relative to glucose. Therefore, according to the method of the present invention, L-valine can be produced industrially and efficiently.
(発明の詳細な説明)
本発明の方法は、微生物菌体の増殖を全く伴わない条件
下に、し−バリンを製造する酵素反応のみによるし一バ
リンの製造法を提供するものである。(Detailed Description of the Invention) The method of the present invention provides a method for producing valine using only an enzymatic reaction for producing valine under conditions that do not involve the growth of microbial cells.
本発明に使用される微生物は、ビオチン要求性のコリネ
型細菌に属するものであり、好ましくはエタノール資化
性のものである。このなかにはL−イソロイシン生産菌
が含まれる。本発明に使用される微生物菌体としては例
えば、ブレビバクテリウム・フラバム(Breviba
cterium flavum) MJ−233(微
工研条寄 第1497号)、ブレビバクテリウム・フラ
バム(Brevibacterium flavu+
w) MJ−233−AB−41(lak工研条寄第1
498号)、ブレビバクテリウム・フラバム(Brev
ibacLerium flavu+*) M J
−233−A BT−11(微工研条寄 第1500号
)及びブレビバクテリウム・フラバム(Breviba
cterium flavu+w) MJ−233−
ABD−21(t3に工研条寄第1499号)等であり
、これらの閃が本発明に好適に用いられる。The microorganisms used in the present invention belong to biotin-requiring coryneform bacteria, and are preferably ethanol-assimilating. This includes L-isoleucine producing bacteria. Examples of the microbial cells used in the present invention include Brevibacterium flavum (Breviba
cterium flavum) MJ-233 (Feikoken Joyori No. 1497), Brevibacterium flavum (Brevibacterium flavu+
w) MJ-233-AB-41 (lak Koken Joyori 1st
498), Brevibacterium flavum (Brev
ibacLerium flavu+*) M J
-233-A BT-11 (Feikoken Joyori No. 1500) and Brevibacterium flavum (Breviba
cterium flavu+w) MJ-233-
ABD-21 (T3 Koken Jyoyori No. 1499) and the like, and these flashes are preferably used in the present invention.
なお、上記の(微工研条寄 第1498号)は(微工研
条寄 第1497号)を親株としてDL−α−アミノ酪
酸耐性を積極的に付与されたエタノール資化性微生物で
ある(特公昭59−28398号公報3〜4欄参照)。The above (Feikoken Joyori No. 1498) is an ethanol-assimilating microorganism that has been actively given DL-α-aminobutyric acid resistance using (Feikoken Joyori No. 1497) as its parent strain ( (See columns 3 and 4 of Japanese Patent Publication No. 59-28398).
(微工研条寄 第1500号)は、(@工研条寄 第1
497号)を親株としたし一α−アミノ酪酸トランスア
ミナーゼ高活性変異株である(特開昭62−51998
号公報参照)、また、(微工研条寄 第1499号)は
(微工研条寄 第1497号)を親株としたD−α−ア
ミノ酪酸デアミナーゼ高活性変異株である(特開昭61
−177993号公報参照)。(Feikoken Joyori No. 1500) is (@Koken Joyori No. 1)
497) as the parent strain, and is a mutant strain with high monoα-aminobutyric acid transaminase activity (Japanese Patent Application Laid-Open No. 62-51998).
In addition, (Feikoken Joyori No. 1499) is a D-α-aminobutyric acid deaminase high activity mutant strain derived from the parent strain (Feikoken Joyori No. 1497) (Japanese Patent Laid-Open Publication No. 61
(Refer to Publication No. 177993).
これらの微生物菌体の他にブレビバクテリウム・アンモ
ニアゲネス(Brevibacterium ammo
niagenes)ATCC6871,同ATCC13
745、同ATCC13746、ブレビバクテリウム・
デバリカタム(Brevibacteriu曽diva
ricatum)ATCC14020等を用いることも
出来る本発明に用いられるビオチン要求性のコリネ型細
菌に属する微生物菌体は、微生物菌体そのままで用いる
こともできるし、又これらを公知の手法で固定化された
固定化物を使用することもできる。この固定化手法とし
ては、菌体をアクリルアミド等の重合性モノマーを用い
たり、アルギン酸塩あるいはカラギーナン等の適当な担
体に不溶化させる等がある。In addition to these microbial cells, Brevibacterium ammonium
niagenes) ATCC6871, ATCC13
745, ATCC 13746, Brevibacterium
Brevibacterium sodiva
ricatum) ATCC 14020, etc. The microorganisms belonging to biotin-requiring coryneform bacteria used in the present invention can be used as they are, or they can be immobilized by known methods. Immobilized products can also be used. This immobilization method includes using a polymerizable monomer such as acrylamide, or making the bacterial cells insoluble in a suitable carrier such as alginate or carrageenan.
本発明の方法に使用される上記のビオチン要求性のコリ
ネ型細菌に属する微生物菌体の調製に使用する培地は、
特に限定されるものではなく一般の微生物に使用される
ものでよい。The medium used for preparing the microbial cells belonging to the above-mentioned biotin-requiring coryneform bacteria used in the method of the present invention is as follows:
There are no particular limitations, and any material used for general microorganisms may be used.
本発明に使用する微生物菌体の調製に使用する培地の窒
素源としてはアンモニア、硫酸アンモニウム、塩化アン
モニウム、硝酸アンモニウム、尿素等を単独若しくは混
合して用いることが出来る無機塩としては、リン酸−水
素カリウム、リン酸二水素カリウム、硫酸マグネシウム
等が用いられる。この他に菌の生育等に必要であれば、
ペプトン、肉エキス、酵母エキス、コーンステイープリ
カー、カザミノ酸、各種ビタミン等の栄養素を培地に添
加し用いる。 培養は通気攪拌、振盪等の好気的条件下
で行い、培養温度は20〜40℃、好ましくは25〜3
5℃で行う。培養途中のpHは5〜lO1好ましくは7
〜8付近にて行い、培養中のp Hの調整には酸、アル
カリを添加して行う。As the nitrogen source for the culture medium used for the preparation of the microorganism cells used in the present invention, ammonia, ammonium sulfate, ammonium chloride, ammonium nitrate, urea, etc. can be used alone or in combination.As the inorganic salt, potassium phosphate-hydrogen can be used. , potassium dihydrogen phosphate, magnesium sulfate, etc. are used. In addition, if necessary for the growth of bacteria, etc.
Nutrients such as peptone, meat extract, yeast extract, cornstarch liquor, casamino acids, and various vitamins are added to the medium. Cultivation is performed under aerobic conditions such as aeration and shaking, and the culture temperature is 20-40°C, preferably 25-30°C.
Perform at 5°C. pH during culturing is 5 to 1O1, preferably 7
The pH is adjusted to around 8 to 8, and acid or alkali is added to adjust the pH during culturing.
培養開始時のグルコース濃度は好ましくは1〜5市T%
、更に好ましくは2〜3重量%が適する、培養期間は0
.5〜3日間、最適期間は1〜2日間である。Glucose concentration at the start of culture is preferably 1-5T%
, more preferably 2 to 3% by weight, and the culture period is 0.
.. 5-3 days, optimal period is 1-2 days.
このようにして得られた培養物から菌体を集めて、水又
は適当な緩ih液で洗浄し、本発明の方法の酵素反応に
使用する。Bacterial cells are collected from the culture thus obtained, washed with water or a suitable slow induction liquid, and used for the enzymatic reaction of the method of the present invention.
本発明の方法においては、上記で調整された微生物菌体
(ここには、その固定化物も含まれる)の存在下、少な
くともグルコースと窒素源を含有する水溶液にて酵素反
応させるに際し、C/N比を2〜45、好ましくは5〜
40に設定し酵素反応を行う0通常用いられるグルコー
ス濃度は、05〜20重量%、好ましくは1−10重量
%である。反応に用いる窒素源の窒素濃度は通常0゜0
1〜4市量%、好ましくは0.02〜2重量%である。In the method of the present invention, C/N ratio from 2 to 45, preferably from 5 to
The glucose concentration usually used is 05-20% by weight, preferably 1-10% by weight. The nitrogen concentration of the nitrogen source used in the reaction is usually 0°0.
The amount is 1 to 4% by weight, preferably 0.02 to 2% by weight.
該水溶液は、通常完全合成培地が好適に用いられるが−
1ここで完全合成培地とは、化学構造が公知の無機窒素
源及び無機塩を含有する水溶液である。本発明に用いら
れる完全合成培地の無機窒素源としては、アンモニア、
塩化アンモニウム、lit酸アンモニウム、硝酸アンモ
ニウム、リン酸アンモニウム等が例示でき、また無機塩
としては、リン酸−水素カリウム、リン酸二水素カリウ
ム、硫酸マグネシウム、硫酸マンガン、硫酸鉄等が例示
される。これらの無機窒素源、無機塩は、単独でも2種
以上混合して用いることもできる。As the aqueous solution, a completely synthetic medium is usually suitably used.
1 Here, the completely synthetic medium is an aqueous solution containing an inorganic nitrogen source and an inorganic salt with a known chemical structure. Inorganic nitrogen sources for the fully synthetic medium used in the present invention include ammonia,
Examples include ammonium chloride, ammonium nitrate, ammonium nitrate, and ammonium phosphate. Examples of inorganic salts include potassium hydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate, manganese sulfate, and iron sulfate. These inorganic nitrogen sources and inorganic salts can be used alone or in combination of two or more.
完全合成培地の一例を示すと、(NH4) 2 S04
23 g/j! ;KH2P 04 0. 5 g/
β;K 2 HP O40、5g / 1 ; M g
S O4・7H200,5g/12 ; FeSO4
H7H2020ppm;MnSO4・4〜6H2020
ppm含有するpH7,6の水溶液がある。An example of a completely synthetic medium is (NH4) 2 S04
23 g/j! ;KH2P 04 0. 5g/
β; K2HP O40, 5g/1; Mg
SO4・7H200,5g/12; FeSO4
H7H2020ppm; MnSO4・4~6H2020
There is an aqueous solution with a pH of 7.6 containing ppm.
上述の様に、本発明に使用される完全合成培地には、ビ
オチン又はビオチンを含む天然物は含有されないやビオ
チンの含有されないことの明らかな化学構造のアミノ酸
、ビタミン、m類等を添加して使用することはできる。As mentioned above, the completely synthetic medium used in the present invention does not contain biotin or natural products containing biotin, or contains amino acids, vitamins, m-types, etc. with chemical structures that clearly do not contain biotin. You can use it.
本発明の方法において使用される、上記の様に調製され
た微生物菌体の使用量は、特に制限されるものではない
が、一般に1〜50%(w L / vol)の濃度で
使用することができる。The amount of the microbial cells prepared as described above used in the method of the present invention is not particularly limited, but is generally used at a concentration of 1 to 50% (w L / vol). Can be done.
本発明において、酵素反応は、約20〜約50℃、好ま
しくは約30〜約40℃の温度で、通常約10〜約72
時間行われる。In the present invention, the enzymatic reaction is carried out at a temperature of about 20 to about 50°C, preferably about 30 to about 40°C, and usually about 10 to about 72°C.
Time is done.
−F記酵素反応は、反応に用いられるグルコース及び窒
素源を含有する水溶液中の溶存酸素濃度がo、O5pp
m以上、sppm以上となる様に、反応系中に空気もし
くはr!!素を、連続又は間歇的に供給して行うのが好
ましい。- In the enzyme reaction described in F, the dissolved oxygen concentration in the aqueous solution containing glucose and nitrogen sources used in the reaction is o, O5pp.
Air or r! is added to the reaction system so that the concentration is at least m and at least sppm. ! It is preferable to supply the element continuously or intermittently.
上記のような反応方法によって得られる反応液中に生成
したし一バリンの分離・精製は、醗酵法によるアミノ酸
の分離・精製と同様に行え、例えば公知のイオン交換樹
脂処理法あるいは、沈澱法等により行うことができる。The separation and purification of valine produced in the reaction solution obtained by the above reaction method can be performed in the same manner as the separation and purification of amino acids by fermentation, for example, by the known ion exchange resin treatment method, precipitation method, etc. This can be done by
′XJL区
以下の実験例において、L−バリンの定性は、ペーパー
クロマトグラフのRf値、電気泳動法の易動度、微生物
定量法による生物活性値により確認した。定量はロイコ
ノストック・メセンテロイデス(Leuconosto
c mesenteroides) A T CC80
42を用いるマイクロバイオアッセイ法と高速液体クロ
マトグラフィー(高滓LC−5A)とを併用して行った
。グルコース残存量の定量は、グルコース定量用キット
(和光純薬工業製ニゲルコースCテスト ワコー)によ
り行った。また、下記の実験例において%と表したのは
重量%を怠味する。'XJL Section' In the following experimental examples, the quality of L-valine was confirmed by the Rf value of paper chromatography, the mobility of electrophoresis, and the biological activity value of microorganism quantification. Quantification was performed using Leuconostoc mesenteroides (Leuconosto mesenteroides).
c mesenteroides) AT CC80
The microbioassay method using 42 was used in combination with high performance liquid chromatography (Takashi LC-5A). The residual amount of glucose was determined using a glucose determination kit (Nigercose C Test Wako, manufactured by Wako Pure Chemical Industries, Ltd.). In addition, in the following experimental examples, the expression % means weight %.
実施例−1
培地(尿素0.4%、硫酸アンモニウム1. 4%、K
Hz PO40,05%、K2 HP 040 。Example-1 Medium (urea 0.4%, ammonium sulfate 1.4%, K
Hz PO40.05%, K2 HP 040.
05%、MgSO4・7H200,05%、CaC1z
・2Hz 0 2ppm、Fe50゜7H202p
pm、MnSO4−4〜6H202ppm+ ZnSO
4・ 7H202ppm。05%, MgSO4・7H200,05%, CaC1z
・2Hz 0 2ppm, Fe50°7H202p
pm, MnSO4-4~6H202ppm+ZnSO
4.7H202ppm.
NaCe 2pI)m、ビオチン 200μg/l、
チアミン・H(1!100μ(H7g、カザミノ酸 0
.1%、酵母エキス0.1%)100mj+を500m
f容三角フラスコに分注、滅菌(滅菌1&pH7,0)
した後ブレビバクテリウム・フラバム(Breviba
cLeriu+m flavum) M J −23
3(微工研条寄 第1497号)を植菌し、無菌的にグ
ルコースを5g//の濃度になるように加え30℃にて
2日間振盪培養を行った。NaCe 2pI)m, biotin 200μg/l,
Thiamin H (1!100μ (H7g, Casamino acid 0
.. 1%, yeast extract 0.1%) 100mj+ for 500m
Dispense into f volume Erlenmeyer flask and sterilize (sterilize 1 & pH 7,0)
After that, Brevibacterium flavum (Breviba
cLeriu+m flavum) M J -23
3 (Kaikoken Joyori No. 1497) was inoculated, and glucose was added aseptically to a concentration of 5 g// to culture with shaking at 30° C. for 2 days.
次に、本培養培地(グルコース5%、硫酸アンモニウム
2.3%、KH2PO40,05%、K、Hl)0.0
.05%、Mg5O,・7H200,05%、Fe50
. ・7H2020ppm、Mn5O4・4−6H2
020ppm、ビオチン 200μg/l、チアミン・
HCI 1100tt/R、カザミノ酸 0.3%、
酵母エキス 0.3%)のIOoomlを21容通気攪
拌槽に仕込み、滅菌(120℃、20分間)後、前記前
培養物の’l Q m lを添加して、回転数1100
Qrp、通気q l v V m 、 ?m度33℃、
p Hl、6にて24時間培養を行った。Next, main culture medium (glucose 5%, ammonium sulfate 2.3%, KH2PO40.05%, K, Hl) 0.0
.. 05%, Mg5O, 7H200, 05%, Fe50
..・7H2020ppm, Mn5O4・4-6H2
020ppm, biotin 200μg/l, thiamin.
HCI 1100tt/R, casamino acid 0.3%,
Yeast extract 0.3%) was placed in a 21-volume aeration stirring tank, and after sterilization (120°C, 20 minutes), 'lQml' of the preculture was added, and the rotation speed was 1100.
Qrp, ventilation q l v V m, ? m degree 33℃,
Culture was carried out at pH 6 for 24 hours.
培養終了後、培養物100m1tずつを遠心分離して集
菌後、説塩蒸留水にて2度洗浄した菌体を反応液〔グル
コース100 g / l 、K H2P O40,5
g/l、K2 HPO40,5g/It、Mg5o、−
78200,5g/1.、FeSO47112020p
pm、チアミン−塩酸塩 100μgel、(pH8,
0))50mfに懸濁後、C/N比が第1表に示した実
験区になるよう窒素源を添加した。なお、窒素源として
硫酸アンモニウムを用いた。またpHm整の為、乾熱滅
菌(150℃、5時間加熱)シた炭酸カルシウムを50
g/12の濃度で添加した。反応は500ml:角フ
ラスコを用い、33℃、回転数22Orpmにて40時
間振盪反応を行った。After the completion of the culture, each 100 ml of the culture was centrifuged to collect the bacteria, and the bacterial cells were washed twice with salt distilled water and added to the reaction solution [glucose 100 g/l, K H2P O40.5
g/l, K2 HPO40,5g/It, Mg5o,-
78200,5g/1. , FeSO47112020p
pm, thiamine-hydrochloride 100 μgel, (pH 8,
After suspending at 50 mf, a nitrogen source was added so that the C/N ratio was as shown in Table 1. Note that ammonium sulfate was used as a nitrogen source. In addition, to adjust the pH, add 50% calcium carbonate that has been dry heat sterilized (heated at 150°C for 5 hours).
It was added at a concentration of g/12. The reaction was carried out using a 500 ml square flask and shaking at 33° C. and a rotational speed of 22 rpm for 40 hours.
反応終了後、遠心骨1itu (4000rpm、 1
5分間、4℃)にて除菌した上清液中のし一バリン量及
びグルコース残量を定量した。After the reaction, distal bone 1 itu (4000 rpm, 1
The amount of valine and the remaining amount of glucose in the supernatant liquid was sterilized at 4° C. for 5 minutes.
結果は第1表に示した。The results are shown in Table 1.
第 1 表 結果を第2表に示した。Table 1 The results are shown in Table 2.
第 2 表
し−バリンd混δマ更(g/1)
L−バリア4弾d口* (g/l)
実施例−2
実施例−1とIi’JMkでブレビバクテリウム・フラ
バム(Brevihactσ1111 fla四−M
J−233−AB−41Gf)tσ研条寄 第1498
号)を培養限また実施1!II−I
L−バリンとグルコース残量
を萌した。2nd table - Valin d mixture δ machining (g/1) L-barrier 4 bullet d mouth * (g/l) Example-2 Brevibacterium flavum (Brevihactσ1111 fla 4) in Example-1 and Ii'JMk -M
J-233-AB-41Gf) tσkenjoyori No. 1498
Issue) will be carried out again as long as it is cultivated! II-I
The remaining amount of L-valine and glucose was determined.
実於伸1−3
実帽列−1と*”M)’ld’L4ごてブレビバクテリ
ウム・フラバムΦrevibacterius+ f
lavm MJ−233−ABT−11@σ扇条寄第1
500号)を培養しまた実8el−I
L−バリンとグルコース残
量を定呈した4
b何列
I トli’?恥で’44牛にて反応させたVゴn勿p
のLバリンとグルコース残Vを定
結果を第3表に示し心
量した
結果を第4表に示した。Shinto 1-3 Real cap row-1 and *”M)'ld'L4 Brevibacterium flavum Φrevibacterius+ f
lavm MJ-233-ABT-11@σ Ogijoyori 1st
No. 500) was cultured and the fruit 8el-I
4 b How many rows I tri'? I was embarrassed and reacted in '44 cow.
Table 3 shows the determination results of L valine and glucose residual V, and Table 4 shows the results of heart measurement.
第
表
第
表
バリン性邦dフ丈(g//)
し
バリン1刃あ間室(g/l)
J】何列−4
実於仲1−1と目”14)’ld!Wでブレビバクテリ
ウム・フラバム小rev i bac ter i m
「1
avu+++) MJ−233
BD
21 Gσ研条寄 第1499号)を培養限また実f切
仄Table 1 Barin style Japanese d Fu length (g//) Shibarin 1 blade gap (g/l) J] What row - 4 Minoru 1-1 and eyes "14)'ld! Brevi with W Bacterium flavum rev i bacter i m
"1 avu+++)
Claims (1)
体を、グルコースと窒素源を含有する水溶液にて酵素反
応させて該溶液中にL−バリンを生成せしめるに際し、
該反応液中のグルコース重量と窒素源の窒素重量の比(
グルコース量/窒素量)を5〜40の範囲で酵素反応を
行うことを特徴とするL−バリンの製造法。(1) When microbial cells belonging to biotin-requiring coryneform bacteria are subjected to an enzymatic reaction in an aqueous solution containing glucose and a nitrogen source to produce L-valine in the solution,
The ratio of the weight of glucose in the reaction solution to the weight of nitrogen in the nitrogen source (
A method for producing L-valine, characterized in that an enzymatic reaction is carried out at a ratio of (glucose amount/nitrogen amount) in the range of 5 to 40.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22141188A JPH0272888A (en) | 1988-09-06 | 1988-09-06 | Production of l-valine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22141188A JPH0272888A (en) | 1988-09-06 | 1988-09-06 | Production of l-valine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0272888A true JPH0272888A (en) | 1990-03-13 |
Family
ID=16766318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22141188A Pending JPH0272888A (en) | 1988-09-06 | 1988-09-06 | Production of l-valine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0272888A (en) |
-
1988
- 1988-09-06 JP JP22141188A patent/JPH0272888A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0272888A (en) | Production of l-valine | |
JP3074781B2 (en) | Production method of L-lysine by fermentation method | |
JPH0347838B2 (en) | ||
JPH0297394A (en) | Treatment of enzymatic catalyst | |
JP2721975B2 (en) | Method for producing L-lysine | |
JPS63267285A (en) | Production of l-valine | |
JPH02273191A (en) | Production of l-valine | |
JPS63269991A (en) | Production of l-isoleucine | |
JPS63112992A (en) | Production of l-threonine | |
JPS63192395A (en) | Production of l-isoleucine | |
JP2721989B2 (en) | Method for producing L-isoleucine | |
JP2721990B2 (en) | Method for producing L-isoleucine | |
CA1150654A (en) | Process for the production of citric acid | |
JPH04293492A (en) | Production of l-valine | |
JPH02211884A (en) | Production of l-isoleucine | |
JPS63192396A (en) | Production of l-isoleucine | |
JPH0314436B2 (en) | ||
JPS63112991A (en) | Production of l-isoleucine | |
JPS63192394A (en) | Production of l-isoleucine | |
JPH02295491A (en) | Preparation of l-isoleucine | |
JPS61177993A (en) | Production of l-isoleucine | |
JPS5835079B2 (en) | Method for producing L-isoleucine | |
JPH0365193A (en) | Production of l-proline | |
JPH04228085A (en) | Production of l-tryptophan | |
JP2582810B2 (en) | Method for producing L-isoleucine |